View the latest clinical trials, studies, data, and updates.
HRCRS will conduct a multi-center observational study through the RWE network of high-volume cardiac electrophysiology centers to collect data on the ensoETM’s effect on throughput and patient outcomes notes Attune Medical.
John Gannon, president and CEO, Blue Spark Technologies. “Where time is critical, continuous temperature monitoring with TempTraq helps clinicians take immediate action the moment that temperature spikes.”
Regenative Labs (will present two scientific studies demonstrating the efficacy of Wharton’s jelly allografts in complicated post-surgical wounds and late-stage sacral decubitus ulcers.
New data just published online in the prestigious journal JAMA Neurology has demonstrated the safety and efficacy of EASEE®, the world’s first minimally invasive brain pacemaker, in patients with focal epilepsy resistant to drug therapy.
“Our bioenergetic wearables are designed to communicate directly to the body, thus triggering its self-repair system,” said Harry Massey, founder and CEO of Energy4Life. “Digitized biological information allows you to help turn on the body’s self-repair system – impacting the physics of the body – which in turn directs all other activity of the body,” stated Massey.
The HYLA Blood sensor is a non-invasive optical blood sensor, being developed using machine learning based algorithms to measure blood key parameters, continuously and in real-time during extracorporeal procedures including VV-ECMO, VA-ECMO and open-heart surgery.